These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 22858088

  • 1. [Carglumic acid for treatment of valproic acid-induced hyperammonaemia in a paediatric patient].
    Gramage Caro T, Vélez-Díaz-Pallarés M, Serna Pérez J, Bermejo Vicedo T.
    Farm Hosp; 2012; 36(5):437-8. PubMed ID: 22858088
    [No Abstract] [Full Text] [Related]

  • 2. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B, Rekarte García S, García López JE, Pérez González C, Montes Granda M, Coto Cotallo GD.
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [Abstract] [Full Text] [Related]

  • 3. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H, Shishido T, Mukai T, Araki M, Naka H, Tokinobu H.
    Rinsho Shinkeigaku; 2019 May 28; 59(5):258-263. PubMed ID: 31061301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X, Li X, Zhang T, Zhao L.
    Basic Clin Pharmacol Toxicol; 2018 Nov 28; 123(5):628-634. PubMed ID: 29791065
    [Abstract] [Full Text] [Related]

  • 6. [L-carnitine in valproic acid-induced hyperammonemia].
    Martín-del Rincón JP, Llompart-Pou JA, Ferreruela M, Velasco J.
    Med Intensiva; 2014 Mar 28; 38(2):124-5. PubMed ID: 23017629
    [No Abstract] [Full Text] [Related]

  • 7. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC, van Meijel JJ.
    Neth J Med; 2011 Sep 28; 69(9):389-91. PubMed ID: 21978982
    [Abstract] [Full Text] [Related]

  • 8. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA, Abdella MM.
    Epilepsy Res; 2009 Sep 28; 86(1):32-41. PubMed ID: 19446440
    [Abstract] [Full Text] [Related]

  • 9. Lacosamide-induced valproic acid toxicity.
    Jones GL, Popli GS, Silvia MT.
    Pediatr Neurol; 2013 Apr 28; 48(4):308-10. PubMed ID: 23498565
    [Abstract] [Full Text] [Related]

  • 10. Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias.
    Chakrapani A, Valayannopoulos V, Segarra NG, Del Toro M, Donati MA, García-Cazorla A, González MJ, Plisson C, Giordano V.
    Orphanet J Rare Dis; 2018 Jun 20; 13(1):97. PubMed ID: 29925411
    [Abstract] [Full Text] [Related]

  • 11. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K, Takahashi T, Yamamoto Y, Suzuki E, Takahashi Y, Imai K, Inoue Y, Hirai K, Tsuji D, Itoh K.
    Seizure; 2015 Dec 20; 33():76-80. PubMed ID: 26599579
    [Abstract] [Full Text] [Related]

  • 12. Use of carglumic acid in the treatment of hyperammonaemia during metabolic decompensation of patients with propionic acidaemia.
    Abacan M, Boneh A.
    Mol Genet Metab; 2013 Aug 20; 109(4):397-401. PubMed ID: 23791308
    [Abstract] [Full Text] [Related]

  • 13. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A, Hernández-Ortíz OH, González-González CA, Amariles P.
    Farm Hosp; 2012 Aug 20; 36(5):441-2. PubMed ID: 22266198
    [No Abstract] [Full Text] [Related]

  • 14. Valproic acid induced hyperammonaemic encephalopathy.
    Amanat S, Shahbaz N, Hassan Y.
    J Pak Med Assoc; 2013 Jan 20; 63(1):72-5. PubMed ID: 23865136
    [Abstract] [Full Text] [Related]

  • 15. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J, Aldenkamp AP, Huizenga JR, Teune LK, Brouwer OF.
    J Clin Psychopharmacol; 2007 Apr 20; 27(2):221-4. PubMed ID: 17414255
    [No Abstract] [Full Text] [Related]

  • 16. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
    Valayannopoulos V, Baruteau J, Delgado MB, Cano A, Couce ML, Del Toro M, Donati MA, Garcia-Cazorla A, Gil-Ortega D, Gomez-de Quero P, Guffon N, Hofstede FC, Kalkan-Ucar S, Coker M, Lama-More R, Martinez-Pardo Casanova M, Molina A, Pichard S, Papadia F, Rosello P, Plisson C, Le Mouhaer J, Chakrapani A.
    Orphanet J Rare Dis; 2016 Mar 31; 11():32. PubMed ID: 27030250
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y, Takahashi Y, Imai K, Mishima N, Yazawa R, Inoue K, Itoh K, Kagawa Y, Inoue Y.
    Epilepsia; 2013 Jun 31; 54(6):983-9. PubMed ID: 23409971
    [Abstract] [Full Text] [Related]

  • 18. [Hyperammonemia secondary to the use of valproic acid: case report].
    Turcato Mde F, Fernandes RM, Wichert-Ana L, Funayama CA.
    Arq Neuropsiquiatr; 2005 Jun 31; 63(2A):364-6. PubMed ID: 16100994
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
    Ozaydin E, Yükselgüngör H, Köse G.
    Eur J Paediatr Neurol; 2008 Mar 31; 12(2):141-3. PubMed ID: 17881258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.